Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets

Danny J Eckert1, David P White, Amy S Jordan

  • 11 Division of Sleep Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Abstract

Insights

Obstructive sleep apnea (OSA) is a heterogeneous disorder with varied causes. Non-anatomic factors, such as muscle responsiveness and arousal threshold, play a significant role in many patients with OSA.

Area of Science:

  • Sleep Medicine
  • Respiratory Physiology

Background:

  • Obstructive sleep apnea (OSA) pathophysiology is not fully understood and likely varies among individuals.
  • Characterizing these diverse causes is crucial for developing targeted therapies.

Purpose of the Study:

  • To quantify the proportion of anatomic and non-anatomic contributions to OSA in a large patient cohort.
  • To identify potential pathophysiologic targets for novel OSA therapies.

Main Methods:

  • Seventy-five adults with and without OSA underwent polysomnography.
  • Evaluated upper airway collapsibility (Pcrit) and non-anatomic factors including genioglossus muscle responsiveness, arousal threshold, and respiratory control stability (loop gain).

Main Results:

  • Pathophysiologic traits varied significantly among OSA patients.
  • 36% showed minimal genioglossus responsiveness, 37% had a low arousal threshold, and 36% exhibited high loop gain.
  • While OSA patients had more collapsible airways, 19% had non-collapsible airways, with higher loop gain compared to those with collapsible airways.

Conclusions:

  • Obstructive sleep apnea is a heterogeneous condition.
  • Both upper airway anatomy (Pcrit) and non-anatomic factors are important determinants of OSA.
  • Non-anatomic abnormalities are prevalent in the majority of OSA patients.

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...